Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
2007-002656-42Phase 3Terminated
Phase 3, randomised, open-label trial of nitroglycerin in anal fissure (2 arms), sponsored by SOFAR. Primary endpoint: Primary efficacy and equivalence endpoint. Started Feb 2008; status: terminated.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on 2007-002656-42.